• Saturday
  • July 26, 2014
  • Last updated: 9:59am
Hong Kong

Humidity 

UV 

Pollution 

Refine Your Search

Sort by

Related Keywords

Search Results

Results 1 - 10 of 264 for drug

Related topics matching your search

Search results

  1. Business - Economy - ANALYSIS

    Sex and drugs to add to Europe's murky GDP figures

    Posted Jun 03rd 2014, 01:30am by BLOOM

    ... Bloomberg New EU economic data rules will put focus on how officials estimate size of grey markets Sex and drugs to add to Europe's murky GDP figures Europe has a new source of economic growth. In the next few months all European Union (EU) countries that do not already include drugs, prostitution, and other illegal and grey-market businesses in their gross domestic ...

    http://www.scmp.com/business/economy/article/1524064/sex-and-drugs-add-europes-murky-gdp-figures
  2. Business - Companies - PHARMACEUTICALS

    Samsung targets low cost drugs as its next growth driver

    Posted May 13th 2014, 01:13am by BLOOM

    ... Bloomberg in Tokyo South Korean electronics giant betting US$2b on biopharmaceuticals to shore up future growth Samsung targets low cost drugs as its next big thing Samsung Group transformed its electronics unit into the world's largest smartphone maker by outselling Apple. Now it is setting its sights on the drug industry. South Korea's biggest company is investing ...

    http://www.scmp.com/business/companies/article/1510759/samsung-targets-low-cost-drugs-its-next-growth-driver
  3. Business - Companies

    R&D spend in biotech outpaces revenue

    Posted Jun 25th 2014, 02:37am by Reuters

    ... obesity. Getting approval for new treatments or drugs is a lengthy process requiring up to three phases of testing under the watch of the US Food and Drug Administration and can take years ... and development of biotech drugs rebounded last year by 14 per cent from 2012, mainly due to a 20 per cent rise in US spending. That uptick caused net income to slip US$8 million to an industry-wide ...

    http://www.scmp.com/business/companies/article/1539911/rd-spend-biotech-outpaces-revenue
  4. News - China - FOOD SAFETY

    Starbucks, Dicos withdraw sandwiches as China launches nationwide probe into 'rotten meat' firm

    Posted Jul 21st 2014, 10:11am by Patrick Boehler

    ... will look at processing sites and meat sources in five other provinces in central, eastern and southern China, the China Food and Drug Administration announced. Violations will be “severely ... full responsibility for the situation and will take appropriate actions swiftly and comprehensively," its statement said. The China Food and Drug Administration has launched ...

    http://www.scmp.com/news/china/article/1556953/mcdonalds-kfc-supplier-closed-shanghai-authorities-investigate-rotten
  5. Business - Companies - IPO

    Neglected Luye finds tonic in HK listing

    Posted Jul 10th 2014, 06:01pm by Doug Young

    ... The old saying "One man's trash can be another man's treasure" certainly seems pertinent for drug firm Luye Pharma (HKEx: 2186), which has found a receptive audience in Hong ... (Nasdaq: GAME). About 60 per cent of those buy-outs were backed by private equity, and the list covered a wide range of industries from drugs, to hotels, to chip makers and IT consultants. I partly ...

    http://www.scmp.com/business/companies/article/1551160/neglected-luye-finds-tonic-hk-listing
  6. Business - China Business - REGULATION

    China's drug safety worries FDA

    Posted Apr 05th 2014, 01:07am by BLOOM

    ... Bloomberg in Washington US regulator seeking to increase staff to carry out more inspections of mainland drug firms China's drug safety worries FDA Improvements are needed in the production of drug ingredients in China to erase the safety risks faced by American consumers, a US regulator said. While the Food and Drug Administration attempts to ensure medicines imported from ...

    http://www.scmp.com/business/china-business/article/1465091/chinas-drug-safety-worries-fda
  7. Business - China Business - CORRUPTION ALLEGATIONS

    Sex video emerges in new twist to China's GlaxoSmithKline bribery scandal

    Posted Jun 30th 2014, 11:17am

    ... of an intimate video recording of its former China head, Mark Reilly, which The Sunday Times reported kicked off a bribery investigation that has damaged the drug maker’s business in China. The Sunday ... Reilly’s whereabouts are unknown. China’s investigation into GSK and its scrutiny of numerous other foreign and local drugs companies have frightened foreign pharmaceutical executives so much ...

    http://www.scmp.com/article/1543450/sex-video-new-twist-gsk-china-bribery-scandal
  8. Business - Money - LISTINGS

    Luye Pharma IPO well received on enthusiasm for health care

    Posted Jul 04th 2014, 01:41am by Jasper Moiseiwitsch

    ... said an analyst with a US brokerage. Luye develops proprietary drugs for the treatment of cancer and heart disease, spending 194 million yuan (HK$244 million) on research last year. It has 22 drugs in development, with four undergoing clinical trials for approval in the US. The issuer delisted from the Singapore Exchange in November 2012. The banker said the firm's principals ...

    http://www.scmp.com/business/money/markets-investing/article/1546094/luye-pharma-ipo-well-received-enthusiasm-health
  9. Business - THE VIEW

    HSBC seems to find it easier to pay fines than fix corporate culture

    Posted Jul 14th 2014, 03:09am by Peter Guy

    ... in physical US dollars from Mexico. According to Taibbi, HSBC played a key role in exchanging currency for Mexican and Colombian drug cartels. HSBC's communications strategy has failed ...

    http://www.scmp.com/business/article/1553555/hsbc-seems-find-it-easier-pay-fines-fix-corporate-culture
  10. Business - China Business - EARNINGS

    Sinopharm to step up drug sales in retail sector

    Posted Mar 25th 2014, 01:32am by Toh Han Shih

    ... Toh Han Shih hanshih.toh@scmp.com Sinopharm to step up sales in retail sector Sinopharm, the mainland's largest drug distributor, plans to boost retail sales to more than 10 billion yuan (HK$12.5 billion) in 2016, said Li Zhiming, the state-owned firm's president. Last year, the firm's drug retail sales rose 17.5 per cent to 4.83 billion yuan. "We ...

    http://www.scmp.com/business/china-business/article/1456559/sinopharm-step-drug-sales-retail-sector

Pages

Login

SCMP.com Account

or